1.a.i) No known problems
1a.ii) Active problem
1.2.1) No allergy records on file
1.2.2) Allergy data may be available (from other systems) but could not be obtained
1.2.3) Patient is not allergic to any medication and this fact has been documented
1.2.4) Patient is allergic to these substances (provide specific list), and where appropriate link to observation event (e.g. Anaphylaxis)
1.2.5) Wide range of allergy types (medications, substances [especially non-consummable], negations, various symptoms, missing RxNorm code, etc.)
1.3.1) Patient is not taking any medications
1.3.2) Medication intervals (B.I.D., T.I.D., Q.I.D., Q.D 1, Q x hrs, etc.)
1.3.3 ) Lifetime does of a medication
1.3.4) Medication history (active/inactive prior medication)
2.1.1) Concern act and observations in problems list
2.1.2) Results organizer and results
2.1.3) Allergy concerns and observations
Lisa and Brian,
Thanks for your joining our effort to create more <section> examples.
I sent 2 <section> example documents, Problem List active and Problem List resolved in my earlier mails..
I want to make 1 more example "Problem List - aborted status." (act.status = aborted)
It is not uncommon to enter a problem in problem list window of EMR and later delete it because we entered wrong information based on wrong history from patient or family.
We probably have to use problem.status =active with negation indicator + ve to say this problem did not exist.
Another example we need is
Problem entered as "difficulty breathing" (complaint)
After 2 weeks (more tests done) , this problem was changed to "congestive heart failure" (diagnosis/disease)
My assumption is to generate another section with same act.id and send another document to recipient, so recipient can update data correctly.
In this scenario we cannot call 'difficulty breathing " as resolved. We changed 1 problem type ( complaint) to another problem type (diagnosis) based on tests conducted.
The more examples we can generate, the better for all involved in interoperability.
Kumara
Right now, we have one good “samples topic” open – “No Known
Problems”. I recommend that we complete that one and in parallel, discuss which
ones we want to cover next.
Can you distill a series of SPECIFIC sub-topics from the broad
“Problem List” topic and can we prioritize them?
For example:
The road to 100s of samples is one sample at a time and the more
narrow and focused the scenario, the more effective it will be. Just look
at how many “sub-agendas” we spun off of “No Known Problems” that we still have
to close out:
· effectiveTime
· DRIV/COMP
· inversionInd
· text reference in a negation
· SNOMED vs. HL7ActClass for code in the Problem Concern Act
· statuscode for Concern vs. Observation
· act.moodcode and act.statuscode
Especially since both you and I are novices, we are going to
have to work through some basic stuff (and will probably need help/guidance on
much of it) first. So, no point in raising tens of issues on one
sample. Let’s start with simple samples and work up from there…
Brian
1) Suggestion from Ed to expand this out to various flavors of "No Known Problems" (such as "No Information Available About Problems") and also to expand it out to allergies, meds, etc.2) Suggestion from Kumara to do two basic specific-problem samples ("Pneumonia - active" and "Pneumonia - resolved").
Remarks in-line
Lisa R. Nelson, MSc, MBA | Consultant | Life Over Time Solutions | cell: 401.219.1165 | Westerly, RI | LisaR...@cox.net
From: ccda_s...@googlegroups.com [mailto:ccda_s...@googlegroups.com] On Behalf Of Brian Weiss
Sent: Thursday, June 06, 2013 7:15 AM
To: ccda_s...@googlegroups.com
Subject: {C-CDA Samples} Samples Team Agenda - Status Update
So far the lead candidates for our next effort after we complete "No Known Problems" is as follows:
1) Suggestion from Ed to expand this out to various flavors of "No Known Problems" (such as "No Information Available About Problems") and also to expand it out to allergies, meds, etc.
[LRN – I agree this is a good idea]
2) Suggestion from Kumara to do two basic specific-problem samples ("Pneumonia - active" and "Pneumonia - resolved"). [I think we should show a life cycle –
Concern is active, it includes two problem observations, both active.
Concern is still active, but now, one of the problem observations has been resolved.
Concern is completed, now, both of the problem observation have been resolved.
3. Not to get too crazy, but I would like to see if anyone else is brave enough to tip toe into the question of data provenance. There is a nuance of what information being documented was authored by the patient or the patient’s device, or comes from the doctor and is informed by the patient, or is just a finding the doctor makes from his/her own observation. Anyone want to fold that in here…or shall we save that for another day? CDA offers the constructs to record this “context” about the information. This would be new territory to actually work out how we could make it work. I’ve been thinking about it a lot and am willing to keep digging if anyone else wants to dig with me.
If anyone wants to take a first cut at those, that would be great. If not, I'll get to them soon.
I think it is very helpful in the process for many contributors to work out WHOLE examples. We should each work out our whole idea for a problem section with the specified example….then review them each…with the author explaining what he developed and why. This will be the best way for us to learn. There could be more than one right answer and this will help us see what CDA makes possible.
Meanwhile, here is what remains for us to close out our first sample of "No Known Problems":
I have views and fundamental principles on this, but I don’t yet have the time to go through all this in this message. I can explain all my theories, and will do so when it is my turn to review my sample with this group. For now, let me say that in the no known problems example, the text element should reference the narrative section text where “no known problems” is written for the humans to read. The originaltext of the code should be “Problem” and it should also reference this text, or more specifically the word “problems”.
--
You received this message because you are subscribed to the Google Groups "C-CDA Samples" group.
To unsubscribe from this group and stop receiving emails from it, send an email to ccda_samples...@googlegroups.com.
To post to this group, send email to ccda_s...@googlegroups.com.
Visit this group at http://groups.google.com/group/ccda_samples?hl=en.
For more options, visit https://groups.google.com/groups/opt_out.
Lisa,
My only issue with your very good suggestion of two observations is that a while back there was a lot of debate about whether (practically) every observation should have its own concern or not. So, I prefer we start with the life-cycle for a single-observation concern and then tackle the potential can of works regarding two observations in one concern.
Similarly, I think we should hold up on provenance as a separate (dedicated) topic. Let’s “crawl” first with the basics and then build up from there. If we get some momentum, eventually we can get braver and tackle tougher samples…
I like your idea about “many contributors working out whole examples” – but right now “many contributors” sounds like a code word for “Lisa and Brian”. So, we might have to build up to that as well...
What I’ll do as soon as my sample is ready is coordinate a convenient time for you and Kumara. I’ll walk through my “proposed final” samples for “No Known Problem” and we’ll review together. If you can bring a samples/samples to that as well, great! We’ll make it a public session that anyone else can also join if they like. How does that sound to start?
Re. Problem Status template (a sub-template of Problem Observation) vs. the statusCode within Problem Observation – that wasn’t me being sloppy, it was me being ignorant! Do you agree, though, that in the current context of “No Known Problems” where the Problem Observation is “generic SNOMED code for ‘a problem’” there is no need for a Problem Status template? As we know, this isn’t really an “observation” – it is more like a “placeholder” so we can say what we want to say about problems in general (negationInd or nullFlavor). Is that right in your view?
I’m going to take your “bottom line” guidance on the text reference as best I understand it, and on the review call we can refine, as you suggest.
Brian
Kumara,
Your “black box” concept (a new flavor of greenCDA) is nice – and I am sure it will help guide our sample selection (which from your perspective is in support of your project, which is fine) - but not sure it will help us much with the hard part here, which is getting the C-CDA XML right.
Of course, whatever input we can get that is helpful is good…
But I think what Lisa and I need most are more people who want to help create C-CDA XML for the various clinical scenarios… so a call-out here to anyone who was interested enough in C-CDA samples to join this Google Group and knows how to “speak C-CDA”. Volunteers very welcome… J
Brian